NCT07059689 High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery
| NCT ID | NCT07059689 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indonesia University |
| Condition | Heart Defects, Congenital |
| Study Type | INTERVENTIONAL |
| Enrollment | 114 participants |
| Start Date | 2025-06-05 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 114 participants in total. It began in 2025-06-05 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery
Eligibility Criteria
Inclusion Criteria: * Patients under 18 years of age. * Post-cardiac surgery patients in the CICU of Cipto Mangunkusumo National General Hospital * Patients at high risk of extubation failure (e.g., young age, open sternotomy, mechanical ventilation \>48 hours). * Patients who pass the extubation readiness test and spontaneous breathing trial. Exclusion Criteria: * Diaphragmatic paralysis. * Decreased consciousness. * Neuromuscular disease. * Pneumothorax without drainage. * Airway obstruction. * Patients with a tracheostomy. * Unplanned extubation. * Patient received PEEP (Positive End-Expiratory Pressure) \>7 prior to extubation
Contact & Investigator
Head of Pediatric Emergency and Intensive Care Divison
PRINCIPAL INVESTIGATOR
Indonesia University
Frequently Asked Questions
Who can join the NCT07059689 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Heart Defects, Congenital. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07059689 currently recruiting?
Yes, NCT07059689 is actively recruiting participants. Contact the research team at dr.yogiprawira@gmail.com for enrollment information.
Where is the NCT07059689 trial being conducted?
This trial is being conducted at Jakarta, Indonesia.
Who is sponsoring the NCT07059689 clinical trial?
NCT07059689 is sponsored by Indonesia University. The principal investigator is Head of Pediatric Emergency and Intensive Care Divison at Indonesia University. The trial plans to enroll 114 participants.